Case Report
Journal of Pharmacy Practice and Community Medicine
Vol. 8
Issue 1
2022
pp. 18-19
Open Access

A Case Report on Bupivacaine Induced Limb Weakness; Type I Augmented Adverse Drug Reaction (ADR)

Jeffin Gloria John1
1Department of Pharmacy Practice, T John College of Pharmacy, Bangalore, Karnataka, INDIA..
Correspondence:

*Jeffin Gloria John

Department of Pharmacy Practice, T John College of Pharmacy, Bangalore, Karnataka, INDIA.

johnjeffin24@gmail.com`

Copyright:

2022 Author(s)

Check for updates
Published:15/05/2022
Received: 09/01/2022
Accepted: 27/03/2022

Abstract

Bupivacaine is an amide-type, long-acting local anesthetic. It acts by preventing generation or conduction of nerve impulses by reducing sodium permeability and increasing action potential threshold.Lower limb motor weakness is a well-known complication of epidural analgesia with local anesthetics. In this case report a 60yr old female developed Bupivacaine induced lower limb weakness post-surgery. This event was identified as Type 1 augmented ADR which was assessed and reported with the help of Naranjo ADR scale. The dose of Bupivacaine was reduced as per clinical pharmacist’s suggestion and that helped in recovery from the weakness on the same day. Type 1 augmented ADR is related to the pharmacological action of the drug or due to the exaggerated pharmacologic response.

Share on Mobile

Scan to access on mobile

Keywords

Bupivacaine
Epidural analgesic
ADR
Limb weakness
Naranjo scale

Content

No content available

Related Articles